Nestlé Clinical Research Unit
Lausanne, Canton of Vaud, 1000, Switzerland
NCT Number: NCT05112146
The aim of this project was to determine if an administration of either 10 g of whey protein isolate or 10 g of whey protein microgels 30 or 10 min before a standard meal could reduce postprandial glucose response in obese subjects.
Looking for future studies?
Notify Me40 year–65 year
All sexes
Interventional
Not applicable
Lausanne, Canton of Vaud, 1000, Switzerland
Monocentric, controlled, randomized, open, complete cross-over study design where participants will take 2 test products or water (negative control) at 2 different time points.
The targeted population will be 16 completely healthy males and females at risk for pre-diabetes.
Primary objective: To quantify the effects of whey protein pre-meals administrated at 30 or 10 min before a meal on post-prandial glucose in the interstitial tissue, as compared to water as negative control.
Secondary objective: To compare glucose response of the different pre-meals (water, whey protein isolate, whey protein micelles).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oral administration
Oral administration
Oral administration
Time frame: Hour 0 to hour 2 after standard meal consumption
Incremental area under the curve
Time frame: Hour 0 to hour 2 after standard meal consumption
Incremental Cmax
Time frame: Hour 0 to hour 2 after standard meal consumption
Incremental Tmax
Société des Produits Nestlé (SPN)
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05887791
Diabetes Mellitus, Endocrine System Diseases
Esslingen am Neckar, Germany
View Trial DetailsNCT06471569
Behavior, Body Weight
Durham, North Carolina, United States
View Trial DetailsNCT06195566
Body Weight, Diabetes Mellitus
Riga, Latvia
View Trial DetailsNCT05724134
Body Weight, Diabetes Mellitus
New York, United States
View Trial Details